After adjustment for demographic and health variables, hazard ratio was 1.94 for individuals with epilepsy and sleep ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

In an update to its guidelines for treating pediatric atopic dermatitis, the American Academy of Pediatrics noted that successful treatment involves the triad of maintenance skin care, topical ...

Female PCPs have higher earnings compared with male PCPs in value-based care, similar earnings in fee-for-service.

In the APOLLO trial, first-line treatment with anlotinib plus penpulimab improved progression-free survival and overall ...

Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

The FDA originally approved Otulfi as a biosimilar in October 2024 based on clinical data that demonstrated the product was highly similar to Stelara.

In a cohort study, researchers evaluated the risk for ischemic and hemorrhagic stroke among individuals with type 1 and type ...

HealthDay News — Adult-onset type 1 diabetes (T1D) is associated with an increased risk for death and major adverse cardiovascular events (MACE), according to a study published in the European Heart ...

HealthDay News — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.